Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
CCG 203971 acts as an antifibrotic agent, inhibiting fibrosis through targeting the MRTF/SRF gene transcription pathway. Inhibits the invasion of prostate cancer cells and acts as a potent anti-proliferative agent.
您的位置：
